BS-194

Name: BS-194
Brand: MedChemExpress
SKU: HY-14372
Rating: 4.5 (1 reviews)

Cat. No.: HY-14372 Purity: 99.36%: FAQs
Data Sheet SDS COA Handling Instructions

Molarity Calculator

BS-194 is an orally active, selective and potent CDK inhibitor. BS-194 inhibits CDK2, CDK1, CDK5, CDK7, CDK9 (IC₅₀s: 3, 30, 30, 250, and 90 nM respectively). BS-194 potently inhibits cancer cells proliferation. BS-194 can be used in the research of cancers like breast cancer, colon cancer.

For research use only. We do not sell to patients.

BS-194 Chemical Structure

CAS No. : 1092443-55-4

Size	Price	Stock	Quantity
5 mg	USD 220	In-stock	Estimated Time of Arrival: December 31
10 mg	USD 340	In-stock	Estimated Time of Arrival: December 31
50 mg		Get quote
100 mg		Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All CDK Isoform Specific Products:

View All Isoforms

CDK1 CDK2 CDK3 CDK4 CDK5 CDK6 CDK7 CDK8 CDK9 CDK11 CDK12 CDK13 CDK14 CDK16 CDK19 CDC CLK Pho85

Biological Activity
Purity & Documentation
References
Customer Review

Description

IC₅₀ & Target^[1]

CDK2

3 nM (IC₅₀)

CDK1

30 nM (IC₅₀)

CDK5

30 nM (IC₅₀)

CDK7

250 nM (IC₅₀)

CDK9

90 nM (IC₅₀)

Cellular Effect

Cell Line	Type	Value	Description	References
A549	GI₅₀	0.2 μM Compound: 4k, BS-194	Antiproliferative activity against human A549 cells after 72 hrs by sulforhodamine B assay Antiproliferative activity against human A549 cells after 72 hrs by sulforhodamine B assay	[PMID: 21080703]
COLO 205	GI₅₀	0.12 μM Compound: 4k, BS-194	Antiproliferative activity against human COLO205 cells after 72 hrs by sulforhodamine B assay Antiproliferative activity against human COLO205 cells after 72 hrs by sulforhodamine B assay	[PMID: 21080703]
HCT-116	GI₅₀	0.1 μM Compound: 4k, BS-194	Antiproliferative activity against human HCT116 cells after 72 hrs by sulforhodamine B assay Antiproliferative activity against human HCT116 cells after 72 hrs by sulforhodamine B assay	[PMID: 21080703]
HepG2	GI₅₀	1 μM Compound: 4k, BS-194	Antiproliferative activity against human HepG2 cells after 72 hrs by sulforhodamine B assay Antiproliferative activity against human HepG2 cells after 72 hrs by sulforhodamine B assay	[PMID: 21080703]
HUVEC	GI₅₀	6.3 μM Compound: 4k, BS-194	Antiproliferative activity against human HUVEC cells after 72 hrs by sulforhodamine B assay Antiproliferative activity against human HUVEC cells after 72 hrs by sulforhodamine B assay	[PMID: 21080703]
MCF-10A	GI₅₀	0.1 μM Compound: 4k, BS-194	Antiproliferative activity against human MCF10A cells after 72 hrs by sulforhodamine B assay Antiproliferative activity against human MCF10A cells after 72 hrs by sulforhodamine B assay	[PMID: 21080703]
MCF7	GI₅₀	0.3 μM Compound: 4k, BS-194	Antiproliferative activity against human MCF7 cells after 72 hrs by sulforhodamine B assay Antiproliferative activity against human MCF7 cells after 72 hrs by sulforhodamine B assay	[PMID: 21080703]
MDA-MB-231	GI₅₀	0.3 μM Compound: 4k, BS-194	Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay	[PMID: 21080703]
PC-3	GI₅₀	0.5 μM Compound: 4k, BS-194	Antiproliferative activity against human PC3 cells after 72 hrs by sulforhodamine B assay Antiproliferative activity against human PC3 cells after 72 hrs by sulforhodamine B assay	[PMID: 21080703]
SAOS-2	GI₅₀	0.25 μM Compound: 4k, BS-194	Antiproliferative activity against human Saos2 cells after 72 hrs by sulforhodamine B assay Antiproliferative activity against human Saos2 cells after 72 hrs by sulforhodamine B assay	[PMID: 21080703]
SK-OV-3	GI₅₀	0.3 μM Compound: 4k, BS-194	Antiproliferative activity against human SKOV3 cells after 72 hrs by sulforhodamine B assay Antiproliferative activity against human SKOV3 cells after 72 hrs by sulforhodamine B assay	[PMID: 21080703]

In Vitro

BS-194 (compound 4k, 72 h) inhibits various cancer cells (MCF-7, MDA-MB-231, MCF-10A, CPLO-205, HCT-116, A549, SaOS2, PC3 ,HepG2, SK-Ov-3) growth, with IC₅₀ values ranging from 100 nM to 1 μM^[1].
BS-194 (10 μM, 24 h) promotes cell cycle arrest in in S and G2/M phases in HCT116 cells^[1].
BS-194 (10 μM, 24 h) inhibits phosphorylation of CDK substrates, and promotes cyclin loss in HCT116 cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cycle Analysis^[1]

Cell Line:	HCT116
Concentration:	0, 0.01, 0.1, 1, 10 μM
Incubation Time:	24 h
Result:	Showed a significant reduction in G1, and increased in S and G2/M phases.

Western Blot Analysis^[1]

Cell Line:	HCT116
Concentration:	0, 0.1, 10, 20 μM
Incubation Time:	0, 0.1, 10, 20 μM
Result:	Inhibited the phosphorylation of the CDK2 substrate RB (retinoblastoma) at Ser-780, Ser-795, Ser-801, Ser-807/Ser-811, and Thr-821. Inhibited levels of cyclin A, cyclin B, and cyclin D1. Inhibited phosphorylation of Thr-170 of CDK2.

In Vivo

BS-194 (compound 4K, intraperitoneal injection, 5 or 10 mg/kg, twice daily for 14 days) inhibits tumor growth with no apparent toxicity in MCF-7 tumor xenografts^[1].
BS-194 (i.p., i.v., p.o., 10 mg/kg) is orally bioavailable, with elimination half-lives of 147 min (i.p.), 210 min (i.v.), and 178 min (p.o.) respectively^[1].
BS-194 (oral gavage, 25 mg/mL) reduces rapid RB and PolII (RNA polymerase II) phosphorylation, but recovery within 24 h in nu/nu-BALB/c athymic nude mice^[1].
BS-194 (oral gavage, 25 mg/kg, daily for 14 days) inhibits tumor growth in HCT116 tumor xenografts, with no significant loss in animal weights^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Nude mice bearing MCF-7 cell^[1]
Dosage:	5 or 10 mg/kg, twice daily for 14 days.
Administration:	Intraperitoneal injection
Result:	Inhibited tumor growth in a dose-dependent manner (30% and 40% reduction at 5 and 10 mg/kg dose, respectively).

Animal Model:	HCT116 tumor xenografts^[1]
Dosage:	25 mg/kg, daily for 14 days.
Administration:	Oral gavage
Result:	Inhibited tumor growth by 50% reduction at 25 mg/kg. Decreased levels of Rb phosphorylation at Ser807/811 and Thr821 (in resected tumors).

Animal Model:

Mice (pharmacokinetic assay)^[1]

Dosage:

10 mg/kg

Administration:

Intraperitoneal injection, intravenous injection, oral administration

Result:

Pharmacokinetic profile of BS-194 (compound 4k).

administration route	dose (mg/kg)	bioavail-ability (%)	C_max (min)	T_1/2 (min)
i.p.	10	73	30	147
p.o.	10	88	15	178
administration route	dose (mg/kg)	T_1/2 (min)	Cl (mL/min/kg)	V_z
i.v.	10	210	5	1391

Molecular Weight

385.46

Formula

C₂₀H₂₇N₅O₃

CAS No.

1092443-55-4

Appearance

Solid

Color

White to off-white

SMILES

OC[C@@H](O)[C@@H](NC1=NC2=C(C(C)C)C=NN2C(NCC3=CC=CC=C3)=C1)CO

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL (259.43 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	2.5943 mL	12.9715 mL	25.9430 mL
5 mM	0.5189 mL	2.5943 mL	5.1886 mL
10 mM	0.2594 mL	1.2972 mL	2.5943 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Calculation results:

Working solution concentration: mg/mL

Purity & Documentation

Purity: 99.36%

Select Batch:

Data Sheet (281 KB) SDS (251 KB)

COA (252 KB) HNMR (264 KB) LCMS (96 KB)

Handling Instructions (2659 KB)

References

[1]. Dean A Heathcote, et al. A novel pyrazolo[1,5-a]pyrimidine is a potent inhibitor of cyclin-dependent protein kinases 1, 2, and 9, which demonstrates antitumor effects in human tumor xenografts following oral administration. J Med Chem. 2010 Dec 23;53(24): [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	2.5943 mL	12.9715 mL	25.9430 mL	64.8576 mL
	5 mM	0.5189 mL	2.5943 mL	5.1886 mL	12.9715 mL
	10 mM	0.2594 mL	1.2972 mL	2.5943 mL	6.4858 mL
	15 mM	0.1730 mL	0.8648 mL	1.7295 mL	4.3238 mL
	20 mM	0.1297 mL	0.6486 mL	1.2972 mL	3.2429 mL
	25 mM	0.1038 mL	0.5189 mL	1.0377 mL	2.5943 mL
	30 mM	0.0865 mL	0.4324 mL	0.8648 mL	2.1619 mL
	40 mM	0.0649 mL	0.3243 mL	0.6486 mL	1.6214 mL
	50 mM	0.0519 mL	0.2594 mL	0.5189 mL	1.2972 mL
	60 mM	0.0432 mL	0.2162 mL	0.4324 mL	1.0810 mL
	80 mM	0.0324 mL	0.1621 mL	0.3243 mL	0.8107 mL
	100 mM	0.0259 mL	0.1297 mL	0.2594 mL	0.6486 mL

BS-194 Related Classifications

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

BS-1941092443-55-4BS194BS 194CDKCyclin dependent kinaseAntitumoranti-cancerMCF-7HCT-116retinoblastomaxenograftsbreast cancercolon cancerInhibitorinhibitorinhibit

Your Recently Viewed Products:

Product Name

Salutation

Applicant Name *

Email Address *

Phone Number *

Organization Name *

Department *

Requested quantity *

Country or Region *

Remarks

Product Name

Lot #

Applicant Name *

Email Address *

Phone Number

Department *

Organization Name *

Country or Region *

Remarks

Name
Email *

	Sorry, but the email address you supplied was invalid.

BS-194

Customer Review

BS-194 Related Antibodies

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All CDK Isoform Specific Products:

Biological Activity

Purity & Documentation

References

Customer Review

BS-194 Related Antibodies

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

BS-194 Related Classifications

Keywords:

Your Recently Viewed Products:

Customer Review

Request for HNMR Report

SAFETY DATA SHEET (SDS)

Request for HNMR Report